| Model Number |
FR99525 |
| Medical Device Problem Codes |
Calcified (1077); Insufficient Device Problem Information (3190); Intravalvular regurgitation (4068)
|
| Health Effect - Clinical Codes |
Calcium Deposits/Calcification (1758); Aortic Valve Insufficiency/ Regurgitation (4450)
|
| Date of Event |
07/01/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that 16 years and 2 months post implant of this aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement.The reason for evaluation was not reported.It was reported that during the evaluation, calcium could be seen in the proximal right coronary artery and in the sinotubular junction.No intervention or adverse patient effects were reported.
|
| |
|
Event or Problem Description
|
|
Additional information received reported the reason for intervention as moderate regurgitation.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Section updated: b.5 g.6 h.2.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information was received that reported subsequently, 2 months later, a transcatheter valve was implanted valve-in-valve.The reason for intervention was reported as aortic insufficiency.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated data: b.1: adv evnt/prod prob: b.2: outcome attributed to adverse event b.3: date of event: b.5: event description e.1: initial reporter h.6: coding.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|